| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sotaro Mori, Takuji Kurimoto, Yusuke Murai, Kaori Ueda, Mari Sakamoto, Norio Chihara, Yuko Yamada-Nakanishi, Makoto Nakamur. Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis. Journal of ophthalmology. vol 2020. 2021-02-26. PMID:33628473. |
although oral prednisolone is the first-line treatment for preventing recurrent optic neuritis (on) after the completion of acute-phase treatment, especially anti-aquaporin 4 (aqp4) antibody-positive on, and anti-myelin oligodendrocyte glycoprotein (mog) antibody-positive on, some patients experience relapses. |
2021-02-26 |
2023-08-13 |
Not clear |
| John J Chen, M Tariq Bhatt. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Current opinion in neurology. vol 33. issue 1. 2021-01-22. PMID:31743235. |
clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin g (mog-igg) optic neuritis. |
2021-01-22 |
2023-08-13 |
Not clear |
| John J Chen, M Tariq Bhatt. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Current opinion in neurology. vol 33. issue 1. 2021-01-22. PMID:31743235. |
to review the clinical characteristics, radiological manifestations and treatment of myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g (igg) optic neuritis. |
2021-01-22 |
2023-08-13 |
Not clear |
| Liming Cao, Lijie Ren, Xuming Huan. Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report. Medicine. vol 100. issue 1. 2021-01-22. PMID:33429822. |
myelin oligodendrocyte glycoprotein (mog) antibody (mog-ab) disease (mog-ad) is a type of demyelinating disease of the central nervous system characterized by a high frequency of optic neuritis (on) attacks. |
2021-01-22 |
2023-08-13 |
Not clear |
| Hirokazu Uchigami, Noritoshi Arai, Mariko Sekiguchi, Atsubumi Ogawa, Tsutomu Yasuda, Akiko Seto, Toshiyuki Takahashi, Sousuke Takeuch. Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: A case report. Multiple sclerosis and related disorders. vol 38. 2021-01-18. PMID:31733424. |
anti-myelin oligodendrocyte glycoprotein antibodies (mog-ab) have been detected in various disorders of the central nervous system including acute disseminated encephalomyelitis (adem), neuromyelitis optica spectrum disorders (nmosd), optic neuritis, myelitis, and cortical encephalitis. |
2021-01-18 |
2023-08-13 |
Not clear |
| Jean-Baptiste Ducloyer, Angelique Caignard, Ramzi Aidaoui, Yolaine Ollivier, Guillaume Plubeau, Sonia Santos-Moskalyk, Lindsay Porphyre, Caroline Le Jeune, Lionel Bihl, Samy Alamine, Romain Marignier, Romain Bourcier, Mathilde Ducloyer, Michel Weber, Guylène Le Meur, Sandrine Wiertlewski, Pierre Lebranch. MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis. The British journal of ophthalmology. vol 104. issue 6. 2021-01-07. PMID:31582363. |
what is the proportion of antibodies to myelin oligodendrocyte glycoprotein (mog-ab) in optic neuritis (on) in adults and what would be the on presentation for which mog-ab should be tested? |
2021-01-07 |
2023-08-13 |
Not clear |
| Mohamed B Hassan, Caroline Stern, Eoin P Flanagan, Sean J Pittock, Amy Kunchok, Robert C Foster, Jiraporn Jitprapaikulsan, David O Hodge, M Tariq Bhatti, John J Che. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. American journal of ophthalmology. vol 220. 2020-12-22. PMID:32707199. |
population-based incidence of optic neuritis in the era of aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies. |
2020-12-22 |
2023-08-13 |
Not clear |
| Mohamed B Hassan, Caroline Stern, Eoin P Flanagan, Sean J Pittock, Amy Kunchok, Robert C Foster, Jiraporn Jitprapaikulsan, David O Hodge, M Tariq Bhatti, John J Che. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. American journal of ophthalmology. vol 220. 2020-12-22. PMID:32707199. |
to re-evaluate the population-based incidence of optic neuritis in the era of aquaporin-4-immunoglobulin g (aqp4-igg) and myelin oligodendrocyte glycoprotein (mog)-igg, which are biomarkers of optic neuritis that is distinct from multiple sclerosis (ms). |
2020-12-22 |
2023-08-13 |
Not clear |
| Tanyatuth Padungkiatsagul, John J Chen, Panitha Jindahra, Tetsuya Akaishi, Toshiyuki Takahashi, Ichiro Nakashima, Takayuki Takeshita, Heather E Mos. Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race. American journal of ophthalmology. vol 219. 2020-12-21. PMID:32681910. |
differences in clinical features of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in white and asian race. |
2020-12-21 |
2023-08-13 |
human |
| Tanyatuth Padungkiatsagul, John J Chen, Panitha Jindahra, Tetsuya Akaishi, Toshiyuki Takahashi, Ichiro Nakashima, Takayuki Takeshita, Heather E Mos. Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race. American journal of ophthalmology. vol 219. 2020-12-21. PMID:32681910. |
to determine whether clinical features and visual outcomes of myelin oligodendrocyte glycoprotein antibody-associated optic neuritis (mog-on) differ between white and asian subjects. |
2020-12-21 |
2023-08-13 |
human |
| Yoshiki Takai, Tatsuro Misu, Kimihiko Kaneko, Norio Chihara, Koichi Narikawa, Satoko Tsuchida, Hiroya Nishida, Takashi Komori, Morinobu Seki, Teppei Komatsu, Kiyotaka Nakamagoe, Toshimasa Ikeda, Mari Yoshida, Toshiyuki Takahashi, Hirohiko Ono, Shuhei Nishiyama, Hiroshi Kuroda, Ichiro Nakashima, Hiroyoshi Suzuki, Monika Bradl, Hans Lassmann, Kazuo Fujihara, Masashi Aok. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain : a journal of neurology. vol 143. issue 5. 2020-12-14. PMID:32412053. |
conformation-sensitive antibodies against myelin oligodendrocyte glycoprotein (mog) are detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic disseminated encephalomyelitis (adem/mdem) and brainstem/cerebral cortical encephalitis, but are rarely detected in patients with prototypic multiple sclerosis. |
2020-12-14 |
2023-08-13 |
Not clear |
| Hao Kang, Hongyang Li, Nanping Ai, Hongjuan Liu, Quangang Xu, Yong Tao, Shihui We. Markedly Elevated Serum Level of T-Helper Cell 17-Related Cytokines/Chemokines in Acute Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Frontiers in neurology. vol 11. 2020-12-08. PMID:33281728. |
markedly elevated serum level of t-helper cell 17-related cytokines/chemokines in acute myelin oligodendrocyte glycoprotein antibody-associated optic neuritis. |
2020-12-08 |
2023-08-13 |
Not clear |
| Chanomporn Narongkhananukul, Tanyatuth Padungkiatsagul, Panitha Jindahra, Chaiyos Khongkhatithum, Lunliya Thampratankul, Kavin Vanikiet. MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison. Clinical ophthalmology (Auckland, N.Z.). vol 14. 2020-12-07. PMID:33273804. |
to compare demographic data, clinical and radiological characteristics, treatment, and long-term visual outcomes between myelin oligodendrocyte glycoprotein autoantibody-positive optic neuritis (mog-igg + on) and aquaporin-4 autoantibody-positive optic neuritis (aqp4-igg + on) in thailand. |
2020-12-07 |
2023-08-13 |
Not clear |
| Athanasios Papathanasiou, Radu Tanasescu, Jillian Davis, Maria Francisca Rocha, Sumeet Singhal, Michael F O'Donoghue, Cris S Constantinesc. MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity. Journal of neurology. vol 267. issue 2. 2020-11-23. PMID:31641876. |
antibodies to myelin oligodendrocyte glycoprotein (mog) have been demonstrated in patients with optic neuritis (on), encephalitis and myelitis. |
2020-11-23 |
2023-08-13 |
Not clear |
| Brigitte Wildemann, Solveig Horstmann, Mirjam Korporal-Kuhnke, Andrea Viehöver, Sven Jariu. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment]. Klinische Monatsblatter fur Augenheilkunde. vol 237. issue 11. 2020-11-19. PMID:33202462. |
[aquaporin-4 and myelin oligodendrocyte glycoprotein antibody-associated optic neuritis: diagnosis and treatment]. |
2020-11-19 |
2023-08-13 |
Not clear |
| Brigitte Wildemann, Solveig Horstmann, Mirjam Korporal-Kuhnke, Andrea Viehöver, Sven Jariu. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment]. Klinische Monatsblatter fur Augenheilkunde. vol 237. issue 11. 2020-11-19. PMID:33202462. |
optic neuritis (on) is a frequent manifestation of aquaporin-4 (aqp4) antibody-mediated neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (mog-em; also termed mog antibody-associated disorders, mogad). |
2020-11-19 |
2023-08-13 |
Not clear |
| Ruth E Rosenstei. New actors in optic neuritis pathogenesis: An Editorial for "Influence of retinal NMDA receptor activity during autoimmune optic neuritis" on page 693. Journal of neurochemistry. vol 153. issue 6. 2020-11-04. PMID:32162696. |
for this purpose, the authors used an optic neuritis model induced by immunisation with myelin oligodendrocyte glycoprotein (aon). |
2020-11-04 |
2023-08-13 |
Not clear |
| Nithisha Thatikonda, Juan Gomez, Eduardo Gonazalez Toled. Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications. The Indian journal of radiology & imaging. vol 30. issue 2. 2020-10-28. PMID:33100693. |
anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: imaging and clinical implications. |
2020-10-28 |
2023-08-13 |
Not clear |
| Lekha Pandit, Douglas Kazutoshi Sato, Sharik Mustafa, Toshiyuki Takahashi, Anitha D'Cunha, Chaithra Malli, Akshatha Sudhir, Kazuo Fujihar. Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India. Multiple sclerosis journal - experimental, translational and clinical. vol 2. 2020-10-01. PMID:28607742. |
relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in india. |
2020-10-01 |
2023-08-13 |
Not clear |
| Rana K Zabad, Renee Stewart, Kathleen M Heale. Pattern Recognition of the Multiple Sclerosis Syndrome. Brain sciences. vol 7. issue 10. 2020-09-30. PMID:29064441. |
these antibody-mediated inflammatory diseases of the cns share a clinical presentation to ms. a number of practical learning points emerge in this review, which is geared toward the pattern recognition of optic neuritis, transverse myelitis, brainstem/cerebellar and hemispheric tumefactive demyelinating lesion (tdl)-associated ms, aquaporin-4-antibody and myelin oligodendrocyte glycoprotein (mog)-antibody nmosd, overlap syndrome, and some yet-to-be-defined/classified demyelinating disease, all unspecifically labeled under |
2020-09-30 |
2023-08-13 |
Not clear |